source
- Forbion raises record €2.3 billion to back 30 European biotech firmsForbion Capital Partners announced it has closed two new funds, the Growth Opportunities Fund IV and Ventures Fund VIII, together raising €2.3 billion, a record for the European life‑sciences ventu…
- TRex Bio targets $111M IPO as Retension and Lycia also prepare public listingsTRex Bio, backed by Eli Lilly, filed with the SEC to raise about $111.3 million by offering 8.3 million shares priced between $14 and $16. If the midpoint price is achieved, the company expects net…